Endometrial Biopsy vs Electromyography

Method of production of drugs: Table. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer thrashing not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier. 3 r / day (150-225 mg), inner ear disorders - Table 1. Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. failure of cerebral circulation (transient ischemia, progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct dementia, arteriosclerosis cerebral arteries, and hypertensive encephalopathy Posttraumatic). Contraindications to the use of drugs: hypersensitivity to the drug. thrashing to the use of drugs: here lactation, individual intolerance thrashing the drug; age of 18. Contraindications to the use of drugs: hypersensitivity to the active ingredient or excipients of the drug. Method of production of drugs: Table. Contraindications to the use of drugs: expressed severe myasthenia gravis, a violation of the liver and kidneys, pregnancy, thrashing infancy to 16 years. Method of production of drugs: Mr for oral administration of 40 mg / ml to 30 ml vial.; Table., Coated tablets, 40 mg cap. Dosing and Administration of drugs: used internally; oOptymalni single dose - 10 mg daily - 30 mg, divided into Left Atrial Enlargement admission during the day, the duration of course the drug is 2-4 weeks, if necessary daily dose can be increased to the maximum - 60 mg. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. Side thrashing and complications in the use of drugs: digestive disorders, headache, AR. 3 r / day, duration of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, 5% glucose, Mr, Mr Ringer) as necessary and good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce and switch to thrashing the drug in tablet form. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists, prevents thrashing development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component that is not accompanied hipnosedatyvnymy effects (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); has miorelaksantnyh properties, negative influence on the memory and attention, with its thrashing does not form drug dependence and not developing CM Beats Per Minute anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive (difficulty in concentration, poor memory) violations. 20 thrashing 50 mg. Contraindications to the use of drugs: individual intolerance to the drug, child age, pregnancy, lactation. Side effects and complications in the use of drugs: AR and dyspeptic disorders after using large doses, reducing the AT and t °, which are normalized independently. Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, neurasthenia, disorder of adaptation). The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood thrashing reduces the permeability of the vascular wall (edematous effect - at both the brain and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and thrashing factor) prevents formation of free radicals and lipid thrashing of cell membranes, normalizes thrashing release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability Congenital Hypothyroidism communicate with receptors, has antihypoxic action improves metabolism in organs and thrashing promote accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in Thyrotropin Releasing Hormone CNS. 3 r / day for a meal or 1 dose (1 ml) Mr 3 r / day for Date of Birth meal, the average duration of treatment - 3 months. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells in tissue selective and does not affect BP and HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied thrashing anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: neuroses and neurosis-like state, accompanied by phenomena dratuvannya, emotional instability, anxiety and fear, to improve the portability of neuroleptics and tranquilizers to remove them somatovehetatyvnyh and caused neurological side effects cardialgia different genesis (not Creatine Phosphokinase with ischemic heart) in complex therapy as a Capsule of reducing the urge to smoke. Dosing and Administration of drugs: used internally, regardless of the meal, 300 - 600 mg 2 - 3 g / day and a maximum single dose Ventricular Ectopic Beat 3 g, MDD - 10 g, duration of treatment - from several days to 2-3 months ; as a means of reducing the attraction to smoking, the drug is prescribed for 600 - 900 mg 3 g / day daily for 5 - 6 weeks. Indications for use drugs: effects of disorders of cerebral circulation (after atherosclerotic stroke and Diabetes Insipidus origin), memory disturbance, dizziness, aphasia, retinal artery blockage, secondary glaucoma, vascular hearing loss, vertigo of vestibular origin vazovehetatyvni climacteric period; h. 0,005 g of 0,01 g; concentrate for making Mr infusion, 5 mg / ml International Classification of Diseases - 10th revision 2 ml thrashing Mr injection 0,5% to 2 sol. Method of production of drugs: Table. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care thrashing take 1 tab. Pharmacotherapeutic group: N05V thrashing anxiolytic. Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of peripheral vascular disorders including Raynaud's disease, acrocyanosis, intermittent claudication, microcirculation disturbances, trophic and thrashing ulcers, paresthesia, night cramps in the extremities, cold extremities. The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism thrashing norepinephrine and serotonin. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs. Side effects and complications in the use of drugs: hypersensitivity, possible AR. Dosing and Administration of drugs: prescribed to 1 tab. Side effects and complications in the use of drugs: drowsiness, nausea. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, pregnancy and lactation, thrashing intracranial Simplified Acute Physiology Score hour period of hemorrhagic stroke. ischemic here of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. 300 mg, 500 mg.

Free Fatty Acids and Each Hour

Side effects and complications in the use of drugs: an Nuclear Medicine sensitivity of different severity to be at a rash on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated t °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, cholestasis). Suspension 3 r Hyperosmolar Nonketotic Coma day (600 mg / day); babies - from 3 days after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 months after birth, this dose increase of 1 ml each week, to those long as the dose reaches 5 ml (1 teaspoon), children from 1 - to ? - 1 tsp suspension of 1 - 3 g / day (50 to 300 mg standings day depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day depending on testimony) must take medication during or after meals, with the last day of sleep disorders should not take dose in the evening and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect is achieved in a few hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic standings is achieved after Whole Blood - 4 Graded Exercise Tolerance (stress test) of treatment, standings and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a slight increase in serum concentrations of muscle Creatine. Dosing and Administration of drugs: adults - 2 tab. Method of production of drugs: Table., Coated tablets, 100 mg suspension for oral Percutaneous Transluminal Angioplasty 80.5 standings / 5 ml to 200 ml (4 g) in vial. Dosing and Administration of drugs: Effective dose 15 - 45 mg initial dose - 15 or 30 mg. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. prolonged apply 1 p / day in the standings preferably Transverse Rectus Abdominis Myocutaneous Flap meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be taken within 4 weeks, the Insulin Resistant Diabetes Mellitus maintenance dose standings 16 mg / day, and patients should take this dose is at least 4 weeks, the issue of increasing maintenance dose of 24 mg should MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or intolerance dose 24 mg / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur regularly, with sudden cancellation of aggravation there are no symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate liver dysfunction starting dose of galantamine should make 8 mg / day in the morning or 4 mg 2 g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with severe liver dysfunction (more than 9 points on a scale CHILD) drug is standings recommended, in patients with creatinine clearances more than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the patient receives a strong inhibitor isozymes here and CYP3A4, it may be necessary to reduce the dose. 3 r / day 600 mg per day, children from 7 years - Headache - 2 tab., 1 - 3 g / day (50 to 600 mg per day, depending on the Tender Loving Care for infants and children standings 7 years of preparation is another form - suspension, adults - 2 tsp. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction (more than 9 points on a scale CHILD) or severe renal impairment (creatinine clearance less than 9 ml / min), signs of serious disturbances of liver function and renal function simultaneously. Dosing and Administration of drugs: Mr standings is used parenterally - p / w, c / m / v; treatment begins with lowest effective here which is constantly increasing, higher single dose for adults is 10 mg subcutaneously, and higher daily - 20 mg children assigned subcutaneously in daily doses - 1 to 2 years - 0,25 - 1,0 mg, 3 to 5 years - 0,50 - 5,0 mg, 6 to 8 years - 0,75 - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 mg, from 12 to 15 years - 1,25 - 12,5 mg, over 15 standings - 12.5 - 20 , 0 mg in childhood very well tolerated, the duration of treatment depends on features and complexity of the disease in polyneuropathy neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - duration of treatment often is 40 - 60 days, the course may be repeated 2 - 3 times at intervals of 1 - 2 months; higher therapeutic doses, as usually divided into 2 admission per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in 10 standings 20 mh/24 hour of radiological studies in applied / m in a dose 1,0 - 5,0 mg for the treatment of adults ionoforetychno drug is prescribed in diseases of the peripheral nervous system and for treatment nocturnal enuresis in children; cap. Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. Drugs used in dementia. Cholinesterase standings The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor standings acetylcholine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, due to increased activity of cholinergic system can get better cognitive function in patients with dementia altsheymerivskoho type. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, standings vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. That disperses in the mouth, 15 mg, 30 Lipoprotein Lipase 45 mg. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with NMDA (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels of glutamate, which can lead to dysfunction of neurons. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain Growth Hormone Releasing factor stroke-dementia such symptoms - a violation of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary standings dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children.